MedPath

To know the effect of guggulu and churna in the management of Amavata w.s.r. to Rheumatoid Arthritis

Phase 4
Conditions
Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
Registration Number
CTRI/2023/03/050329
Lead Sponsor
Rajiv Gandhi Govt Post Graduate Ayrvedic College and Hospital Paprola
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient willing for study

Age group 30-70 years will be selected for the study

Patients with signs and symptoms of Amavatar wsr. to Rheumatoid Arthritis as described in classical texts and fulfill the diagnostic criteria.

Exclusion Criteria

1. Patients not willing for the study.

2. Patients below age of 30 years and above 70 years of age.

3. Patients suffering from cardiac, respiratory, P.T.B. Malignancy, Patient already taking chemotherapy, radiotherapy. Pregnant and Lactating women. Allergy to the research drug or any other condition considered to be Unfit for enrollment in the trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief in symptoms of amavata after intervention of vatari guggulu and shatpushpadi churna with simhanada guggulu <br/ ><br> <br/ ><br>Morning stiffness <br/ ><br>Generalised body aches <br/ ><br>Reduced appetite <br/ ><br>Thirst <br/ ><br>Lethargy <br/ ><br>Indigestion <br/ ><br>Joints pain <br/ ><br>Constipation <br/ ><br>Disturbed sleep <br/ ><br>Burning sensation <br/ ><br>Nausea <br/ ><br>Timepoint: 6 weeks
Secondary Outcome Measures
NameTimeMethod
Improving quality of lifeTimepoint: 6 Weeks
© Copyright 2025. All Rights Reserved by MedPath